CD8A and rheumatoid arthritis: Consistent with our previous report on B cells from patients with rheumatoid arthritis (41), this study reveals that extrafollicular PD-L1hi plasmablasts, which precede the GC response, can operate in vitro as modulatory cells on PD-1 expressing CD8+ T cells, providing new insights that could be harnessed for cell targeting immune therapies.